Hancock Whitney’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $606K | Buy |
1,362
+19
| +1% | +$8.46K | 0.01% | 523 |
|
|
2025
Q1 | $651K | Sell |
1,343
-184
| -12% | -$89.2K | 0.02% | 391 |
|
|
2024
Q4 | $615K | Sell |
1,527
-1,181
| -44% | -$476K | 0.02% | 399 |
|
|
2024
Q3 | $1.26M | Sell |
2,708
-79
| -3% | -$36.7K | 0.04% | 276 |
|
|
2024
Q2 | $1.31M | Sell |
2,787
-5
| -0.2% | -$2.34K | 0.04% | 256 |
|
|
2024
Q1 | $1.17M | Buy |
2,792
+101
| +4% | +$42.2K | 0.04% | 278 |
|
|
2023
Q4 | $1.09M | Sell |
2,691
-93
| -3% | -$37.8K | 0.04% | 297 |
|
|
2023
Q3 | $968K | Buy |
2,784
+33
| +1% | +$11.5K | 0.04% | 306 |
|
|
2023
Q2 | $968K | Buy |
2,751
+208
| +8% | +$73.2K | 0.04% | 318 |
|
|
2023
Q1 | $801K | Buy |
2,543
+725
| +40% | +$228K | 0.03% | 336 |
|
|
2022
Q4 | $525K | Buy |
1,818
+2
| +0.1% | +$578 | 0.02% | 423 |
|
|
2022
Q3 | $526K | Buy |
1,816
+18
| +1% | +$5.21K | 0.02% | 406 |
|
|
2022
Q2 | $507K | Sell |
1,798
-290
| -14% | -$81.8K | 0.02% | 418 |
|
|
2022
Q1 | $545K | Buy |
2,088
+101
| +5% | +$26.4K | 0.02% | 440 |
|
|
2021
Q4 | $436K | Buy |
1,987
+24
| +1% | +$5.27K | 0.01% | 509 |
|
|
2021
Q3 | $356K | Buy |
1,963
+24
| +1% | +$4.35K | 0.01% | 542 |
|
|
2021
Q2 | $391K | Sell |
1,939
-113
| -6% | -$22.8K | 0.01% | 617 |
|
|
2021
Q1 | $441K | Sell |
2,052
-1,753
| -46% | -$377K | 0.02% | 576 |
|
|
2020
Q4 | $899K | Sell |
3,805
-35
| -0.9% | -$8.27K | 0.03% | 402 |
|
|
2020
Q3 | $1.05M | Sell |
3,840
-440
| -10% | -$120K | 0.04% | 360 |
|
|
2020
Q2 | $1.24M | Sell |
4,280
-55
| -1% | -$16K | 0.05% | 333 |
|
|
2020
Q1 | $1.03M | Buy |
4,335
+135
| +3% | +$32.1K | 0.04% | 359 |
|
|
2019
Q4 | $920K | Sell |
4,200
-201
| -5% | -$44K | 0.03% | 455 |
|
|
2019
Q3 | $746K | Sell |
4,401
-134
| -3% | -$22.7K | 0.02% | 499 |
|
|
2019
Q2 | $832K | Sell |
4,535
-51
| -1% | -$9.36K | 0.03% | 500 |
|
|
2019
Q1 | $844K | Buy |
4,586
+35
| +0.8% | +$6.44K | 0.03% | 506 |
|
|
2018
Q4 | $754K | Buy |
4,551
+1,935
| +74% | +$321K | 0.03% | 475 |
|
|
2018
Q3 | $504K | Buy |
+2,616
| New | +$504K | 0.01% | 640 |
|